Start slowly, monitor your bodys response, and work with your provider to ensure safety and effectiveness
When you go off a GLP-1, your body wants to restore its balance
Data collection and base year analysis are done using data collection modules with large sample sizes
The best outcomes come from medically supervised care that combines the right therapy with protein, resistance training, metabolic monitoring, and an individualized long-term plan
So much of the experimentation with GLP-1s is happening outside traditional research models, careful clinical trials and even the health system
Sinai Hospital, Toronto, Canada summarize and elucidate evidence that glucagon-like peptide-1 (GLP-1) receptor agonists (RAs), initially developed for the treatment of type 2 diabetes and weight management, demonstrate a surprisingly broad range of clinical benefits